Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

2.0K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

202
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
202
Infection01:20

Infection

11.3K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.3K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

3.0K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.0K
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

84
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
84
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

82
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
82

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current state of knowledge on medical cannabis use and risk for infections: A practical guide for clinicians.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Prognostic Value of Lung Injury Biomarkers in Patients Hospitalized With COVID-19 Without Respiratory Failure at Admission.

Critical care medicine·2026
Same author

Can Influenza virus cause bacteremia, sepsis, and septic shock?

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

In sepsis, a tailored precision immunotherapy strategy improved organ function at 9 d.

Annals of internal medicine·2026
Same author

Inhaled Antibiotics for Ventilator-Associated Pneumonia: Is It Ready for Prime Time?

Critical care medicine·2026
Same author

Advancing the Prevention of Surgical Site Infections Through Antibiotic Prophylaxis.

Anaesthesia, critical care & pain medicine·2026
Same journal

Higher BMI is associated with greater fatigue and dyspnea in interstitial lung disease: a Pulmonary Fibrosis Foundation Registry study.

Annals of the American Thoracic Society·2026
Same journal

Social Drivers in COPD: Securing Better Outcomes May Start with Food.

Annals of the American Thoracic Society·2026
Same journal

Blood Pressure Change After Six-minute Walk Test Is an Independent Predictor of Clinical Worsening in Patients with Pulmonary Hypertension.

Annals of the American Thoracic Society·2026
Same journal

Co-designing a Palliative Care Referral Tool for Patients with Fibrosing Interstitial Lung Disease.

Annals of the American Thoracic Society·2026
Same journal

Use of the Wnt/β-catenin Activator Lithium Is Associated with Less Emphysema.

Annals of the American Thoracic Society·2026
Same journal

Housing mobility program effects on ambient fine particulate matter exposure and childhood asthma morbidity.

Annals of the American Thoracic Society·2026
See all related articles

Related Experiment Video

Updated: Apr 25, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
08:58

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes

Published on: March 3, 2023

8.8K

Emerging and resistant infections.

Cornelius J Clancy1, Andre C Kalil, Vance G Fowler

  • 11 Department of Medicine.

Annals of the American Thoracic Society
|August 23, 2014
PubMed
Summary
This summary is machine-generated.

Optimizing antibiotic use for ventilator-associated pneumonia (VAP) is crucial to combat drug resistance. Shorter treatment durations and de-escalation strategies show promise in reducing antibiotic consumption without compromising patient outcomes.

Keywords:
Staphylococcus aureusinfluenzapneumoniaventilator-associated pneumonia

More Related Videos

Time-Lapse Epifluorescence Microscopy Imaging of Pseudomonas aeruginosa and Staphylococcus aureus Heterogeneous Phenotypes
07:44

Time-Lapse Epifluorescence Microscopy Imaging of Pseudomonas aeruginosa and Staphylococcus aureus Heterogeneous Phenotypes

Published on: February 14, 2025

1.7K
Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

1.3K

Related Experiment Videos

Last Updated: Apr 25, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
08:58

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes

Published on: March 3, 2023

8.8K
Time-Lapse Epifluorescence Microscopy Imaging of Pseudomonas aeruginosa and Staphylococcus aureus Heterogeneous Phenotypes
07:44

Time-Lapse Epifluorescence Microscopy Imaging of Pseudomonas aeruginosa and Staphylococcus aureus Heterogeneous Phenotypes

Published on: February 14, 2025

1.7K
Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

1.3K

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Microbiology

Background:

  • Ventilator-associated pneumonia (VAP) presents a significant mortality risk (24-50%) and is a major driver of antimicrobial resistance.
  • The optimal antibiotic therapy duration for VAP remains undetermined, with prolonged courses exacerbating resistance.
  • Staphylococcus aureus is a primary pathogen in VAP, with infection outcomes influenced by complex host-pathogen-environment interactions.

Purpose of the Study:

  • To explore strategies for optimizing antibiotic therapy duration in VAP to mitigate antimicrobial resistance.
  • To investigate the role of host genetics and bacterial factors in S. aureus pathogenesis and VAP outcomes.
  • To highlight the impact of advanced sequencing technologies on understanding pathogen evolution and drug resistance.

Main Methods:

  • Review of de-escalation strategies including clinical resolution, fixed durations (7-8 days), and procalcitonin monitoring.
  • Analysis of genome-scale studies focusing on S. aureus strains, host responses, and genetic factors.
  • Application of next-generation sequencing for influenza molecular epidemiology, evolution, and transmission studies.

Main Results:

  • De-escalation strategies and fixed-duration therapies can decrease antibiotic use with comparable outcomes to longer courses, except possibly for Pseudomonas aeruginosa VAP.
  • Genome-scale studies are refining the understanding of VAP pathogenesis driven by S. aureus.
  • Deep sequencing reveals significant influenza genetic diversity and the presence of pre-existing or transmissible drug-resistant strains.

Conclusions:

  • Optimizing antibiotic duration and employing de-escalation strategies are key to combating VAP and antimicrobial resistance.
  • Understanding host-pathogen interactions through genomic approaches is vital for improving VAP treatment.
  • Advanced sequencing technologies are essential for tracking pathogen evolution, transmission, and resistance, particularly for influenza and VAP pathogens.